These interactions suggest that targeting EDNRB and MME might be beneficial for therapeutic strategies, enhancing the understanding of NSCLC’s and play a crucial role in advancing treatment strategies and improving the effectiveness of targeted therapies for patients with NSCLC. This evidence concerns the gene MME and non-small cell lung carcinoma.